{"id":2283,"date":"2017-10-09T15:11:22","date_gmt":"2017-10-09T13:11:22","guid":{"rendered":"https:\/\/www.nanexa.com\/?p=2283"},"modified":"2020-05-10T15:11:46","modified_gmt":"2020-05-10T13:11:46","slug":"nanexa-undersoker-pharmashell-i-ny-djurstudie-2","status":"publish","type":"post","link":"https:\/\/nanexa.com\/sv\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/","title":{"rendered":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie"},"content":{"rendered":"<p>Baserat p\u00e5 de goda resultaten fr\u00e5n den djurstudie med PharmaShell\u00ae som genomf\u00f6rdes under tredje kvartalet 2017 har Nanexa beslutat genomf\u00f6ra ytterligare en djurstudie. Den nya studien som just startats kommer \u00e4ven den studera dep\u00e5effekt av PharmaShell\u00ae men under avsev\u00e4rt l\u00e4ngre tid \u00e4n den tidigare studien. Studien genomf\u00f6rs p\u00e5 Charles River Laboratories prekliniska enhet i Skottland.<\/p>\n<p>F\u00f6r mer information kontakta:<\/p>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)<\/p>\n<p>Telefon: 0709 &#8211; 42 83 03<\/p>\n<p>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\">david.westberg@nanexa.se<\/a><\/p>\n<p>www.nanexa.com<\/p>\n<p>Om Nanexa AB (publ)<\/p>\n<p>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell<sup>\u00ae<\/sup> som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<sup>\u00ae<\/sup> har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Baserat p\u00e5 de goda resultaten fr\u00e5n den djurstudie med PharmaShell\u00ae som genomf\u00f6rdes under tredje kvartalet 2017 har Nanexa beslutat genomf\u00f6ra ytterligare en djurstudie. Den nya studien som just startats kommer \u00e4ven den studera dep\u00e5effekt av PharmaShell\u00ae men under avsev\u00e4rt l\u00e4ngre tid \u00e4n den tidigare studien.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-2283","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Baserat p\u00e5 de goda resultaten fr\u00e5n den djurstudie med PharmaShell\u00ae som genomf\u00f6rdes under tredje kvartalet 2017 har Nanexa beslutat genomf\u00f6ra ytterligare en djurstudie. Den nya studien som just startats kommer \u00e4ven den studera dep\u00e5effekt av PharmaShell\u00ae men under avsev\u00e4rt l\u00e4ngre tid \u00e4n den tidigare studien.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-09T13:11:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-10T13:11:46+00:00\" \/>\n<meta name=\"author\" content=\"bastardreklam\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"bastardreklam\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/\"},\"author\":{\"name\":\"bastardreklam\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/68861ce2615a32f1e9a8a421cd4e604d\"},\"headline\":\"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie\",\"datePublished\":\"2017-10-09T13:11:22+00:00\",\"dateModified\":\"2020-05-10T13:11:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/\"},\"wordCount\":140,\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"articleSection\":[\"Nyheter\"],\"inLanguage\":\"sv-SE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/\",\"name\":\"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2017-10-09T13:11:22+00:00\",\"dateModified\":\"2020-05-10T13:11:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/person\\\/68861ce2615a32f1e9a8a421cd4e604d\",\"name\":\"bastardreklam\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g\",\"caption\":\"bastardreklam\"},\"url\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/author\\\/bastardreklam\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB","og_description":"Baserat p\u00e5 de goda resultaten fr\u00e5n den djurstudie med PharmaShell\u00ae som genomf\u00f6rdes under tredje kvartalet 2017 har Nanexa beslutat genomf\u00f6ra ytterligare en djurstudie. Den nya studien som just startats kommer \u00e4ven den studera dep\u00e5effekt av PharmaShell\u00ae men under avsev\u00e4rt l\u00e4ngre tid \u00e4n den tidigare studien.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/","og_site_name":"Nanexa AB","article_published_time":"2017-10-09T13:11:22+00:00","article_modified_time":"2020-05-10T13:11:46+00:00","author":"bastardreklam","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"bastardreklam","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/#article","isPartOf":{"@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/"},"author":{"name":"bastardreklam","@id":"https:\/\/nanexa.com\/#\/schema\/person\/68861ce2615a32f1e9a8a421cd4e604d"},"headline":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie","datePublished":"2017-10-09T13:11:22+00:00","dateModified":"2020-05-10T13:11:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/"},"wordCount":140,"publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"articleSection":["Nyheter"],"inLanguage":"sv-SE"},{"@type":"WebPage","@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/","url":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/","name":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2017-10-09T13:11:22+00:00","dateModified":"2020-05-10T13:11:46+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/nanexa-undersoker-pharmashell-i-ny-djurstudie-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Nanexa unders\u00f6ker PharmaShell\u00ae i ny djurstudie"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nanexa.com\/#\/schema\/person\/68861ce2615a32f1e9a8a421cd4e604d","name":"bastardreklam","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/62836a2290061bb860a6ef73affdbedf9d7377d872b392c7b91b47027427a5db?s=96&d=mm&r=g","caption":"bastardreklam"},"url":"https:\/\/nanexa.com\/sv\/author\/bastardreklam\/"}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/2283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/comments?post=2283"}],"version-history":[{"count":1,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/2283\/revisions"}],"predecessor-version":[{"id":2284,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/posts\/2283\/revisions\/2284"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=2283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/categories?post=2283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/tags?post=2283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}